DOMENICA study (GINECO-EN105b/ENGO-Ten13): randomized phase III trial in MMR deficient (MMRd) endometrial cancer (EC) patients comparing chemotherapy (CT) alone versus dostarlimab in first line advanced/metastatic setting (APGOT-EN1). - Chel Hun Choi; Ray-Coquard, Isabelle; Rubio, Maria Jesus; Paoletti, Xavier; Hudson, Emma; Lorusso, Domenica; Hasler-Strub, Ursula; Vardar, Mehmet Ali; Lheureux, Stéphanie; Van Gorp, Toon; Shao Peng Tan, David; Trillsch, Fabian; et al. (Journal of Gynecologic Oncology, 2024)